BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caldeira LF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLoS One 2020;15:e0238910. [PMID: 32946509 DOI: 10.1371/journal.pone.0238910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Zhang T, Sun J, Liu N. Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Front Cell Infect Microbiol 2022;12:899845. [DOI: 10.3389/fcimb.2022.899845] [Reference Citation Analysis]
2 Parodi B, Kerlero de Rosbo N. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease? Front Immunol 2021;12:718220. [PMID: 34621267 DOI: 10.3389/fimmu.2021.718220] [Reference Citation Analysis]
3 Park SY, Seo GS. Fecal Microbiota Transplantation: Is It Safe? Clin Endosc 2021;54:157-60. [PMID: 33827154 DOI: 10.5946/ce.2021.072] [Reference Citation Analysis]
4 Lam S, Bai X, Shkoporov AN, Park H, Wu X, Lan P, Zuo T. Roles of the gut virome and mycobiome in faecal microbiota transplantation. The Lancet Gastroenterology & Hepatology 2022;7:472-84. [DOI: 10.1016/s2468-1253(21)00303-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chen C, Chen L, Sun D, Li C, Xi S, Ding S, Luo R, Geng Y, Bai Y. Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis. Gut Pathog 2022;14:20. [PMID: 35619175 DOI: 10.1186/s13099-022-00491-3] [Reference Citation Analysis]
6 Guzzo GL, Andrews JM, Weyrich LS. The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izab343] [Reference Citation Analysis]
7 Tunç U, Yıldırım Y, Çelebi ARC, Kepez Yıldız B. Potential role of ocular surface microbiota in keratoconus etiopathogenesis. Expert Review of Ophthalmology 2021;16:333-41. [DOI: 10.1080/17469899.2021.1942844] [Reference Citation Analysis]
8 Bunt DV, Minnaard AJ, El Aidy S. Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases. Pharmaceuticals (Basel) 2021;14:506. [PMID: 34073220 DOI: 10.3390/ph14060506] [Reference Citation Analysis]
9 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2021. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Reference Citation Analysis]
10 Ke S, Weiss ST, Liu Y. Rejuvenating the human gut microbiome. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.05.005] [Reference Citation Analysis]
11 Green JE, Davis JA, Berk M, Hair C, Loughman A, Castle D, Athan E, Nierenberg AA, Cryan JF, Jacka F, Marx W. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes 2020;12:1-25. [PMID: 33345703 DOI: 10.1080/19490976.2020.1854640] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Sanders DJ, Inniss S, Sebepos-Rogers G, Rahman FZ, Smith AM. The role of the microbiome in gastrointestinal inflammation. Biosci Rep 2021;41:BSR20203850. [PMID: 34076695 DOI: 10.1042/BSR20203850] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Borody TJ, Dolai S, Gunaratne AW, Clancy RL. Targeting the microbiome in Crohn's disease. Expert Rev Clin Immunol 2022. [PMID: 35731859 DOI: 10.1080/1744666X.2022.2093186] [Reference Citation Analysis]
14 Thomson P, Núñez P, Quera R, Bay C. Gastrointestinal microbiome, what is behind faecal microbiota transplantation? New Microbes New Infect 2021;42:100898. [PMID: 34168881 DOI: 10.1016/j.nmni.2021.100898] [Reference Citation Analysis]
15 Layunta E, Buey B, Mesonero JE, Latorre E. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis. Front Endocrinol (Lausanne) 2021;12:748254. [PMID: 34819919 DOI: 10.3389/fendo.2021.748254] [Reference Citation Analysis]
16 Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Boccuto L, Scarpellini E, Kobyliak N, Abenavoli L. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina (Kaunas) 2022;58:84. [PMID: 35056392 DOI: 10.3390/medicina58010084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]